M.Sc

Applications are invited for following purely temporary posts (likely to continue for three years and subject to change without any prior information) in the Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, Govt. of India, sponsored research project entitled, Development of primary human microglial/astrocyte cell-based model for neurodegenerative diseases under Principal Investigator Prof. Shailendra Saxena, Stem Cell/Cell Culture Lab, Dept. of Centre for Advanced Research (CFAR), KGMU, Lucknow.

Delhi Pharmaceutical Sciences and Research University (DPSRU), is the first Pharmacy University of India established by an Act7 of 2008 of State Legislature of Delhi as a State University vide Notification No.F. 2(412)/2008/SB/Vol. II/71 dated 21.01.2010 and is empowered to award degrees as specified by the UGC under section 22 of the UGC Act 1956 through its own departments and constituent colleges in regular mode vide notification No. F.9-19/2015/(CPP-I/PU) dated 22nd September 2015.

Anna University Chennai Regional Office Tiruchirappalli (Formerly Anna University Tiruchirappalli) has been established as a Anna University Chennai Regional Office Tiruchirappalli by the Government of Tamilnadu. The Regional Office is functioning from 01-08-2012 at Tiruchirappalli, which is famously known as Rock Fort city. The Regional Office is situated 17Kms away in the main highway of Tiruchirappalli to Pudukkottai.

NIAB is an autonomous and premier institute of the Department of Biotechnology (DBT), Government of India. The Institute aims to develop and harness novel and emerging biotechnological tools and applications, and take up research in cutting-edge areas for improving animal health and productivity as well as contribute to human health and welfare.

The Indian Registry of Pathology was established in 1965 under the auspices of the Indian Council of Medical Research in New Delhi, India as a Centre for collection and distribution of teaching material in pathology. The Registry was renamed in 1980 as the National Institute of Pathology (IOP) in view of its expanded scope and activities.

Hetero is a globally renowned vertically integrated pharmaceutical player engaged in research and development, manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas. Backed by 27 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, Global Generics, Biosimilars and Custom Pharmaceutical Services. The company is among the largest producers of Active Pharmaceutical Ingredients in the world.

Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India. Intas success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, Biotechnology and global operations over three decades.

23rd Oct 2021 (9.00am to 5.00pm)

Amoli has been working collaboratively with some of the leading global healthcare players since 3 decades. Our strength comes from our expertise in process chemistry further bolstered by our EDQM and USFDA approved facilities allowing us to cater to the needs of the pharmaceutical industry globally.

Established in 1984, the Institute of Microbial Technology (IMTech) is one among the chain of 37 national laboratories, 6 units and 39 outreach centres of the Council of Scientific & Industrial Research. Set-up to be a fore-runner in the niche domain of microbial biotechnology, the Institute in its initial years functioned from a start-up laboratory that provided a truly world-class R&D ambience in an area of over 10,000 sq. ft. to its researchers.